Four firms – Accord, Alissa Healthcare Research, Lexon and King Pharmaceutials – have been fined by the UK’s Competition and Markets Authority over price-fixing and information-sharing activities related to the supply of nortriptyline.
The fines imposed by the CMA come to more than £3.4m ($4.4m) in total, with a further £1m payment to...





